Tarsus Pharmaceuticals financial statements

타서스 파머슈티컬스NASDAQ:TARS · Nasdaq · Healthcare · sector #13
$74.45+1.99%
2026-10-05 close

Tarsus Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $183M. 2024 operating profit was −$123M.

Reported results

Tarsus Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q